• LAST PRICE
    2.1300
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    2.1100/ 1
  • Ask / Lots
    2.3400/ 21
  • Open / Previous Close
    2.1300 / 2.1300
  • Day Range
    Low 2.1200
    High 2.1885
  • 52 Week Range
    Low 1.3100
    High 5.0300
  • Volume
    77,557
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 2.13
TimeVolumeLXRX
09:32 ET28792.1885
09:33 ET8092.12
09:35 ET15002.14
09:37 ET2002.15
09:39 ET12002.145
09:42 ET4002.14
09:48 ET9822.1315
09:53 ET3002.14
10:00 ET3002.13
10:04 ET1002.125
10:06 ET22002.14
10:09 ET14002.14
10:11 ET6002.155
10:13 ET3002.16
10:15 ET1002.16
10:20 ET2002.155
10:22 ET1002.16
10:24 ET23632.15
10:26 ET2552.145
10:27 ET2852.1443
10:29 ET25812.14
10:31 ET1492.145
10:33 ET1032.145
10:36 ET1002.15
10:38 ET1002.15
10:40 ET1002.1499
10:42 ET3002.15
10:44 ET3002.148
10:45 ET2222.145
10:47 ET2202.1425
10:49 ET1002.145
10:54 ET1002.15
10:56 ET1002.145
10:58 ET1002.1499
11:00 ET47532.135
11:03 ET1002.135
11:12 ET28002.13
11:14 ET6392.125
11:18 ET1002.125
11:20 ET1002.125
11:21 ET14022.135
11:23 ET1002.14
11:27 ET2002.14
11:30 ET2002.14
11:32 ET1002.14
11:36 ET1002.14
11:38 ET1002.1399
11:43 ET2002.135
11:52 ET1002.14
11:57 ET1002.13
12:01 ET5002.13
12:08 ET8082.135
12:15 ET1002.14
12:17 ET6002.135
12:21 ET8002.1375
12:24 ET1002.1328
12:26 ET23412.125
12:28 ET1002.125
12:30 ET3002.125
12:32 ET2002.125
12:33 ET7002.125
12:37 ET86322.14
12:39 ET6092.14
12:42 ET2002.135
12:44 ET12002.1315
12:46 ET1002.13
12:48 ET4002.14
12:50 ET3002.14
12:51 ET41982.1214
12:53 ET1002.13
12:55 ET1002.125
12:57 ET16172.12
01:00 ET76192.13
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesLXRX
Lexicon Pharmaceuticals Inc
402.0M
-3.4x
---
United StatesNUVB
Nuvation Bio Inc
399.7M
-3.6x
---
United StatesAURA
Aura Biosciences Inc
404.8M
-7.3x
---
United StatesPHAT
Phathom Pharmaceuticals Inc
396.6M
-2.0x
---
United StatesKOD
Kodiak Sciences Inc
394.4M
-1.1x
---
United StatesGLUE
Monte Rosa Therapeutics Inc
410.4M
-3.9x
---
As of 2022-11-27

Company Information

Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Its pipeline includes Sotagliflozin, LX9211, and LX2761. Sotagliflozin is an orally-delivered small molecule compound that is being developed for the treatment of heart failure and type I diabetes, and type II diabetes, heart failure and chronic kidney disease. LX9211 is an orally-delivered small molecule compound that is being developed for the treatment of neuropathic pain. The Company is conducting a Phase II clinical trial of LX9211 in diabetic peripheral neuropathic pain and a second Phase II clinical trial of LX9211 in post-herpetic neuralgia. LX2761 is an orally-delivered small molecule compound that is designed to inhibit sodium-glucose cotransporter 1 (SGLT1) locally in the gastrointestinal tract without any inhibition of sodium-glucose cotransporter 2 (SGLT2) in the kidney.

Contact Information

Headquarters
8800 TECHNOLOGY FOREST PLACE 8800 TECHNOLOGY FOREST PLACETHE WOODLANDS, TX, United States 77381
Phone
281-863-3000
Fax
281-863-8088

Executives

Independent Chairman of the Board
Raymond Debbane
President, Chief Financial Officer
Jeffrey Wade
Chief Executive Officer, Director
Lonnel Coats
Executive Vice President - Innovation and Chemical Sciences
Alan Main
Senior Vice President, General Counsel
Brian Crum

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$402.0M
Revenue (TTM)
$125.0K
Shares Outstanding
188.7M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.35
EPS
$-0.63
Book Value
$0.76
P/E Ratio
-3.4x
Price/Sales (TTM)
3,215.9
Price/Cash Flow (TTM)
---
Operating Margin
-76,649.60%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.